CRXT Insider Trading Activity and SEC Form 4 Filings
CRXT insider trading summary
No open-market insider purchases or sales of Clarus Therapeutics Inc (CRXT) have been reported on SEC Form 4 in the past 12 months.
Latest CRXT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 20, 2022 | Thomas, McNerney & Partners II L.P. | 10% Owner | Sell | $34K (13,630 @ $2.53) |
| Apr 20, 2022 | TMP Associates II LP | 10% Owner | Sell | $34K (13,630 @ $2.53) |
| Apr 20, 2022 | TMP Associates II LP | 10% Owner | Sell | $4.2M (1,663,126 @ $2.53) |
| Apr 20, 2022 | Tmp Associates LP | 10% Owner | Sell | $14K (5,722 @ $2.53) |
| Apr 20, 2022 | TMP Nominee II, LLC | 10% Owner | Sell | $4.2M (1,663,126 @ $2.53) |
| Apr 20, 2022 | Thomas, McNerney & Partners II, LLC | 10% Owner | Sell | $4.2M (1,663,126 @ $2.53) |
| Apr 20, 2022 | James E Thomas | 10% Owner | Sell | $4.2M (1,663,126 @ $2.53) |
| Apr 20, 2022 | Thomas McNerney & Partners LP | 10% Owner | Sell | $5.2M (2,061,685 @ $2.53) |
| Apr 20, 2022 | TMP Nominee, LLC | 10% Owner | Sell | $14K (5,722 @ $2.53) |
| Apr 20, 2022 | Tmp Associates LP | 10% Owner | Sell | $5.2M (2,061,685 @ $2.53) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.